CONNECT CapitalMatch with BioMed Ventures @ CONNECT
Jun 3 @ 11:30 am



BioMed Ventures Logo CYMK

About BioMed Ventures

BioMed Ventures is the strategic investment arm of BioMed Realty (NYSE: BMR), the leading provider of real estate solutions to the life science community with approximately 18 million square feet of facilities in the major life science markets throughout the United States and United Kingdom.


Bruce Steel
Managing Director
BioMed Ventures
About Bruce Steel
Bruce is the founder and Managing Director of BioMed Ventures and serves on the leadership team of BioMed Realty. He maintains extensive relationships with leading institutional investors, world-class entrepreneurs, and top executives developed over fifteen years of investing and operating in the biotech sector. Bruce was Chief Executive Officer and co-founder of Rincon Pharmaceuticals from 2005 until its acquisition in 2008; previously he was Chief Business Officer at Anaphore and Head of Corporate Development at Ambit Biosciences. Bruce received his Bachelor of Arts degree from Dartmouth College, his Masters of Business Administration degree from the Marshall School of Business at the University of Southern California, and he holds the designation of Chartered Financial Analyst.
Nancy Hong
BioMed Ventures
About Nancy Hong
Nancy joined BioMed Ventures in April 2013. Previously she was a senior analyst at Forward Ventures and advised biotech and pharma companies, including the Genomics Institute of the Novartis Research Foundation, entering new areas of research. From 2003 to 2006 Nancy was a senior scientist at Phenomix where she directed a scientific group, managed pharma collaborations, and evaluated research opportunities. Nancy received a Bachelor of Science with honors in biology from the California Institute of Technology, a PhD in Molecular and Cellular Biology from the University of California at Berkeley, and subsequent training in immunology and oncology as a postdoctoral fellow of the Leukemia & Lymphoma Society with Nobel-laureate Dr. J. Michael Bishop at the University of California, San Francisco.



Investment Criteria

  • Private companies in the life science sector broadly defined as: therapeutics, devices, industrial/agricultural, and diagnostics
  • Some proof of concept or very strong data to suggest positive outcomes
  • Companies currently institutionally-backed or financing will include broader institutional syndicate
  • Financing will enable company operations by enabling completion of clear, value-creating milestone(s)
  • Location agnostic

About Capital Match

CONNECT provides portfolio and member companies opportunities to meet with private equity investors, venture capital firms, and angel investors. CONNECT, on behalf of the featured investor, solicits proposals from local companies seeking investment capital. CONNECT organizes a morning or afternoon session open to early stage and mid-market companies to network and hear from the featured investor about their investment strategy, followed by one-on-one presentations from pre-selected companies to the investor.

Location:  CONNECT 8950 Villa La Jolla Drive, Suite A-124 La Jolla, CA 92109


Application Deadline: May 22, 2015

Contact:Ginny Merrifield
Vice President, Business Development

and Strategic Partnerships
P (858) 964-1302



CONNECT Operations Roundtable Presents: Is Mexico the Next China? Advantages of Returning Manufacturing to our Region @ TrellisWare Technologies, Inc.
Jun 10 @ 7:00 am – 9:30 am



The CONNECT Operations Roundtable Presents:

Is Mexico the Next China? 
Advantages of Returning Manufacturing to our Region 

In the increasingly competitive global marketplace manufacturers continually strive to reduce costs in order to increase, or simply maintain, market share. For the past 15 years cost reduction has been a key factor in the decision many companies made to outsource their manufacturing to Asia, especially China.Today the advantages of manufacturing in China are eroding: cost savings are dwindling, quality is lacking, IP theft is rampant, and companies are worried about counterfeit parts. With supply chain dynamics changing rapidly, manufacturers have an opportunity to re-examine and optimize their supply chains. Many companies are rethinking manufacturing options and choosing to return those operations to Mexico and the United States. Should you?Our experts will consider and discuss:

  • Reasons several companies have returned manufacturing to the San Diego region and strategies to return more manufacturing to our bi-national region
  • “Reshoring” – when to consider it and how to select which parts or products to reshore
  • Lessons learned from case stories of companies that have near-sourced to Mexico


David Mayagoitia, AICP
Industrial Investment Engineering (IN3)
Former Chairman of the Board
Tijuana EDC

About the Speakers:

David Mayagoitia has over 30 years experience in the promotion, development, and management of industrial real estate focused on foreign manufacturing investment in Mexico.

Mayagoitia has been heavily involved in community building for the cross-border region. He was the founding CEO of Mexico’s Industrial Park Association (AMPIP) and a founding member of Tijuana’s Economic Development Corporation, where he was Chairman of the Board in 2012-2013. He also served on the Board of Tijuana´s Private Sector Coordination Committee and the Economic Development Council from 2011 to 2013,  the Board of the San Diego Regional EDC, the Advisory Board of the San Diego Tijuana ULI, and was Chairman of the CALIBAJA Mega-region in 2013.

Michele Nash-Hoff
ElectroFab Sales
Michele Nash-Hoff is president of ElectroFab Sales, a manufacturers rep agency, and author of Can American Manufacturing Be Saved—Why We Should and How We Can www.savingusmanufacturing.comShe is currently a director on the national board of the American Jobs Alliance, a director on the board of the San Diego Inventors Forum, and Chair of the California chapter of the Coalition for a Prosperous America. She is a columnist for Industry Week’s e-newsline, and an authorized speaker on behalf of the Reshoring Initiative
Elliot L. Shev
General Manager of Sales & Operations

Sumitronics USA, Inc.
Elliot L. Shev, is the General Manager of Sales and Operations for Sumitronics USA, Inc. a Sumitomo Corporation Group company.Shev has over 40 years’ experience working in the electronics industry. He has held senior management positions in sales, operations, service, and marketing working in the mainframe computer arena, computer graphics industries, software, and the electronics manufacturing services industry.


Wednesday, June 10, 2015                                   

light continental breakfast starting at 7:00am

TrellisWare Technologies, Inc.
16516 Via Esprillo, Suite 300
Multipurpose (MPR) Room 361
San Diego, CA 92127

$40 General Admission
Complimentary Admission for CONNECT members provided by CMTC  


reg here

CMTC’s Mission: To create solutions for manufacturing growth and profitability. CMTC is a private, mission-based non-profit Corporation, affiliated with the National Institute of Standards and Technology’s (NIST) Hollings Manufacturing Extension Partnership (MEP). Our affiliation assures performance standards that translate into customer service with consistent high benefits and satisfaction.
TrellisWare Technologies is a privately held company in San Diego, California. We are dedicated to improving and changing the design and performance of communications and signal processing systems. As a worldwide leader in highly advanced algorithms, waveforms, and communications systems, we provide innovative small form factor radio products, and fully integrated solutions. TrellisWare is delivering the next generation of communications to military and commercial markets – today.
trans-lineFor more information contact Cindy McHugh, Director of Programs | (858) 964-1341 or
Rock Stars of Innovation @ Sanford Consortium for Regenerative Medicine
Jun 10 @ 7:30 am – 6:30 pm



June 10, 2015

Keynote Speakers Announced!

Agenda Announced!

Kevin-Murphy copy

Kevin Murphy, M.D.

Vice Chair, Director of Central Nervous System Tumors and Pediatric Radiation Oncology Services
UC San Diego Moores Cancer Center

Dr. Murphy’s clinical and research interests focus on the development and application of a number of novel technologies and therapeutic approaches to the cancers of the central nervous system in both adults and children, and which includes Frameless Stereotactic Radiosurgery (SRS), Intensity Modulated Stereotactic Radiosurgery (IM-SRS), and Hypofractionated Stereotactic Radiosurgery. He is a frequent invited speaker on these technologies at national and international seminars. Dr. Murphy is also at the forefront of studies which use Magnetic Resonance Therapy  (MRT) in the treatment of chemo brain, autism and PTSD (post-traumatic stress disorder). Dr. Murphy received his M.D. from the University of Chicago’s Pritzker School of Medicine and completed his Radiation Oncology Residency in the Department of Radiation and Cellular Oncology at the University of Chicago.


Kurzrock Photo copy

Razelle Kurzrock, M.D.

Senior Deputy Center Director, Clinical Science
UC San Diego Moores Cancer Center

Dr. Razelle Kurzrock is known for developing the largest Phase 1 clinical trials department in the nation/world while at the University of Texas M.D. Anderson Cancer Center. That program’s central theme was personalized medicine strategy and utilized a protocol employing advanced molecular technologies to match patients with targeted treatments that are more likely to work for their individual needs.

At Moores Cancer Center, Dr. Kurzrock’s charge is broad, including not just growing and innovating the center’s clinical trials program, but also heading its newly established Center for Personalized Cancer Therapy, which focuses on precision medicine trials, using the most innovative genomically-targeted drugs and/or agents that arm the immune system. In addition to her world-recognized work in translational science, Dr. Kurzrock has an extraordinary expertise and experience in clinical research and regulatory operations and which includes over 500 peer-reviewed publications and a strong record of competitive grant funding within the setting of Phase I program building, among others.


June 10, 2015


Program:                     8:00am – 4:30pm (registration begins at 7:30am)
Sunset Reception:      4:30pm – 6:30pm


Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037


7:30am      Registration, Breakfast

8:00am      Welcome Remarks


8:15am      Keynote Speaker

Precision Cancer Medicine: Harnessing Genomics and the Immune System is Transforming the Clinic

Razelle Kurzrock, Senior Deputy Center Director, Clinical Science, UC San Diego Moores Cancer Center

8:45am      Cutting Edge Developments in Regenerative Medicine

Moderated by Jay Lichter, Managing Director, Avalon Ventures

Steve Flaim, Co-Founder, CEO and Director, CardioCreate, Inc.

Alysson Muotri, Professor of Pediatrics/Cellular & Molecular Medicine, UC San Diego School of Medicine

Shyni Varghese, Professor of Bioengineering, UC San Diego

9:30am      Fireside Chat

Christian Braemer, CEO and Co-Founder, Benefunder

Michael Jackson, Senior Vice President, Drug Discovery & Development, Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute

10:00am      Break

11:00am      How Nanotechnology Platforms are Changing the Therapeutic Landscape

Moderated by Melissa Fitzgerald, Senior Director, Global Scouting-San Diego, External Research & Development Innovation, Pfizer

Bradley Messmer, Founder and CEO, Abreos Biosciences

Jose Morachis, CEO, NanoCellect Biomedical, Inc.

Liangfang Zhang, Professor of NanoEngineering/Moores Cancer Center, UC San Diego

11:45am      Lunch

1:15pm       Keynote Speaker

Magnetic Resonance Therapy: A Novel Approach in the Treatment of Neurocognitive Disorders

Kevin Murphy, Vice Chair, Director of Central Nervous System Tumors and Pediatric Radiation Oncology Services, UC San Diego Moores Cancer Center

1:45pm      Diagnostic Tools – New Advances and Latest Developments in Technology

Moderated by Jack Young, Senior Director, Qualcomm Ventures; General Partner, dRx Capital

Drew Hall, Professor of Electrical & Computer Engineering, UC San Diego

Royan Kamyar, CEO and Founder, Owaves

Raj Krishnan, CEO, Biological Dynamics

2:30pm      Fireside Chat

Diego Miralles, Global Head of Innovation, Janssen Research and Development

Evan Snyder, Professor/Director, Center for Stem Cell & Regenerative Medicine, Sanford-Burnham Medical Research Institute

3:00pm      Break

3:30pm      Applications and Breakthroughs in Tissue Engineering and Bioprinting – What’s Next?

Moderated by David Webb, Adjunct Professor, The Scripps Research Institute

Shaochen Chen, Professor and Vice Chair of NanoEngineering/Bioengineering, UC San Diego

Karen Christman, Professor of Bioengineering, Sanford Consortium for Regenerative Medicine/UC San Diego

Keith Murphy, Chairman and CEO, Organovo

4:15pm      Closing Remarks


4:30pm      Sunset Reception

6:30pm      Conclude


About Rockstars of Innovation:

Rock Stars of Innovation Summit is an annual, day-long gathering which showcases cutting-edge discoveries and ground-breaking innovations originating from San Diego’s acclaimed research institutions, eminent corporations and leading start-ups.

Now in its 7th year, the Summit serves as a forum that brings together forward-thinking leaders and science/technology-minded individuals interested in hearing about the latest breakthroughs in research and the next wave of disruptive technologies. Featuring a mix of keynotes, panel discussions and informal conversations, Rock Stars of Innovation is designed with ample opportunities for networking in a relaxing and welcoming setting. The format is tailored to foster early conversations among researchers, innovators, strategic partners, and capital providers to share ideas and develop potential partnerships.